Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir

BACKGROUND: Immunocompromised populations, such as organ transplant recipients and patients with inflammatory bowel disease (IBD) receiving immunosuppressive/immunomodulatory medications, may be more susceptible to coronavirus infections. However, little is known about how immunosuppressants affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yining, Li, Pengfei, Lavrijsen, Marla, Rottier, Robbert J., den Hoed, Caroline M., Bruno, Marco J., Kamar, Nassim, Peppelenbosch, Maikel P., de Vries, Annemarie C., Pan, Qiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256998/
https://www.ncbi.nlm.nih.gov/pubmed/37226653
http://dx.doi.org/10.1002/ueg2.12417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256998/
https://www.ncbi.nlm.nih.gov/pubmed/37226653
http://dx.doi.org/10.1002/ueg2.12417

Ejemplares similares